Exacerbations of COPD are associated with worsening of the airflow obstruction,
hospitalisation, reduced quality of life, disease progression and death. At least 70% of …

Respiratory diseases cause a high incidence and mortality worldwide. As a natural
immunobiotic, Lactobacillus has excellent immunomodulatory ability. Administration of some …

Background Concomitant seasonal influenza vaccination with a COVID-19 vaccine booster
could help to minimise potential disruption to the seasonal influenza vaccination campaign …

Recent approval of mRNA vaccines for emergency use against COVID-19 is likely to
promote rapid development of mRNA-based vaccines targeting a wide range of infectious …

Influenza is a common respiratory infection associated with a substantial clinical, humanistic,
and economic burden globally. Vaccines are essential to prevent and control influenza and …

Background Respiratory syncytial virus (RSV) causes severe respiratory illnesses in infants
and older adults. Older adults are frequently hospitalized with RSV illness and may …

Importance Current data identifying COVID-19 risk factors lack standardized outcomes and
insufficiently control for confounders. Objective To identify risk factors associated with COVID …

Background Persistent symptoms of SARS‐CoV‐2 are prevalent weeks to months following
the infection. To date, it is difficult to disentangle the direct from the indirect effects of SARS …

Pathogenic viruses cause many human, animal, and plant diseases that are associated with
substantial morbidity, mortality and socio-economic impact. Although effective strategies for …

Importance Despite widespread use, summary evidence from prior meta-analyses has
contradictory conclusions regarding whether oseltamivir decreases the risk of hospitalization …